Literature DB >> 15813929

Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment.

A R Carta1, E Tronci, A Pinna, M Morelli.   

Abstract

Early gene induction by L-DOPA in the striatum of dopamine denervated rats represents a useful way to study long-term modifications produced by this drug. The effects of acute and subchronic L-DOPA administration on zif-268 mRNA expression were compared in 6-hydroxydopamine-lesioned rats. Rats received a subchronic intermittent L-DOPA (6 mg/kg) treatment, which produces behavioural sensitization, a correlate of dyskinetic movements. Three days after interruption of subchronic treatment, zif-268 mRNA was evaluated after an L-DOPA challenge. Zif-268 mRNA levels increased in the lesioned dorsolateral striatum after either acute or subchronic L-DOPA administration. Double labelling of striatal cells with zif-268 and enkephalin or dynorphin mRNA probes was performed to assess neuronal activation in the indirect and direct output pathway. Single acute L-DOPA significantly increased zif-268 in all striatal neurons reflecting a hyperresponsiveness of dopamine-depleted striatum. After subchronic L-DOPA, zif-268 mRNA labelling was still increased in the striatonigral pathway, limited to dynorphin(+) neurons, whereas in all other neurons it was similar to the control value. Results suggest that striatal neurons responding to acute L-DOPA differ from those responding to subchronic L-DOPA. L-DOPA-induced behavioural sensitization was associated to a down-regulation in the responsiveness of striatopallidal and striatonigral dynorphin(-) neurons, whereas in striatonigral neurons containing dynorphin a hyperresponsiveness to L-DOPA was observed. High levels of zif-268, together with a persistent hyperresponsiveness of striatonigral dymorphinergic neurons and hyporesponsiveness of striatopallidal neurons, by creating an unbalanced state of striatal efferent neurons, may be implicated in dyskinetic movements observed in Parkinson's disease (PD).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15813929     DOI: 10.1111/j.1460-9568.2005.03944.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  16 in total

1.  A 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey model.

Authors:  Kimberly E Vanover; Adrienne J Betz; Suzanne M Weber; Francesco Bibbiani; Aiste Kielaite; David M Weiner; Robert E Davis; Thomas N Chase; John D Salamone
Journal:  Pharmacol Biochem Behav       Date:  2008-10       Impact factor: 3.533

2.  Metabotropic glutamate mGluR5 receptor blockade opposes abnormal involuntary movements and the increases in glutamic acid decarboxylase mRNA levels induced by l-DOPA in striatal neurons of 6-hydroxydopamine-lesioned rats.

Authors:  N Yamamoto; J-J Soghomonian
Journal:  Neuroscience       Date:  2009-08-04       Impact factor: 3.590

3.  Comparing movement patterns associated with Huntington's chorea and Parkinson's dyskinesia.

Authors:  Rena K Mann; Roderick Edwards; Julie Zhou; Alison Fenney; Mandar Jog; Christian Duval
Journal:  Exp Brain Res       Date:  2012-03-21       Impact factor: 1.972

4.  The selective kappa-opioid receptor agonist U50,488 reduces L-dopa-induced dyskinesias but worsens parkinsonism in MPTP-treated primates.

Authors:  Heather Cox; Daniel M Togasaki; Li Chen; J William Langston; Donato A Di Monte; Maryka Quik
Journal:  Exp Neurol       Date:  2007-02-03       Impact factor: 5.330

Review 5.  Neurocomputational models of basal ganglia function in learning, memory and choice.

Authors:  Michael X Cohen; Michael J Frank
Journal:  Behav Brain Res       Date:  2008-10-04       Impact factor: 3.332

6.  GluN2A and GluN2B NMDA receptor subunits differentially modulate striatal output pathways and contribute to levodopa-induced abnormal involuntary movements in dyskinetic rats.

Authors:  Omar S Mabrouk; Flora Mela; Mariangela Calcagno; Mirco Budri; Riccardo Viaro; Andrzej Dekundy; Christopher G Parsons; Yves P Auberson; Michele Morari
Journal:  ACS Chem Neurosci       Date:  2013-04-23       Impact factor: 4.418

7.  Time-course of SKF-81297-induced increase in glutamic acid decarboxylase 65 and 67 mRNA levels in striatonigral neurons and decrease in GABA(A) receptor alpha1 subunit mRNA levels in the substantia nigra, pars reticulata, in adult rats with a unilateral 6-hydroxydopamine lesion.

Authors:  N Yamamoto; J-J Soghomonian
Journal:  Neuroscience       Date:  2008-04-16       Impact factor: 3.590

8.  Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors.

Authors:  Jenny E Westin; Linda Vercammen; Elissa M Strome; Christine Konradi; M Angela Cenci
Journal:  Biol Psychiatry       Date:  2007-07-26       Impact factor: 13.382

9.  A neurocomputational account of catalepsy sensitization induced by D2 receptor blockade in rats: context dependency, extinction, and renewal.

Authors:  Thomas V Wiecki; Katrin Riedinger; Andreas von Ameln-Mayerhofer; Werner J Schmidt; Michael J Frank
Journal:  Psychopharmacology (Berl)       Date:  2009-01-24       Impact factor: 4.530

10.  Progressive dopaminergic degeneration in the chronic MPTPp mouse model of Parkinson's disease.

Authors:  Nicoletta Schintu; Lucia Frau; Marcello Ibba; Arianna Garau; Ezio Carboni; Anna R Carta
Journal:  Neurotox Res       Date:  2009-05-27       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.